PTX
Click for more information
0.00% 4.0¢ prescient therapeutics limited

VHL - Transgene TG4011 & TG4010, page-5

  1. psych101
    1,075 Posts.
    lightbulb Created with Sketch. 43
    clock Created with Sketch.
    16/01/17
    20:13
    Post #: 21931178
    Cornhulio, following link on current proceedings.
    December 7, 2016 - UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) / The trial will be supported by Transgene and Bristol-Myers Squibb http://www.transgene.fr/wp-content/...7-Collaboration_UC_Davis_Transgene-BMS_EN.pdf
    PTX Price at posting: 8.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Resolute Mining down 10% on first US$80M payment to Mali's government
right-arrow Created with Sketch.
RMS High-grade Gold and Copper findings drive excitement at Red Mountain’s Flicka Lake
right-arrow Created with Sketch.
NEWS 'Major potential': Nanocap Forrestania hits 222g/t gold rock chip at Bonnie Vale
right-arrow Created with Sketch.
NEWS Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban
right-arrow Created with Sketch.
NEWS EQR looks to become 'preeminent Western tungsten producer' with key acquisition
right-arrow Created with Sketch.
NEWS Smallcap Radiopharm notches +12% jump on pancreatic cancer imaging win
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.